edetic acid has been researched along with mycophenolic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bonthuis, F; de Bruin, RW; Hesselink, DA; Mathot, RA; van Gelder, T; van Hest, RM; Weimar, W | 1 |
1 review(s) available for edetic acid and mycophenolic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for edetic acid and mycophenolic acid
| Article | Year |
|---|---|
Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.
Topics: Animals; Area Under Curve; Bilirubin; Cyclosporine; Drug Synergism; Edetic Acid; Glucuronides; Graft Rejection; Immunosuppressive Agents; Male; Membrane Transport Modulators; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Mycophenolic Acid; Organ Transplantation; Placebos; Rats; Rats, Wistar; Tacrolimus; Time Factors | 2005 |